.png){kind=icon}
.png){kind=icon}
Return
Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4
.png){kind=icon}
OA
AI
DOI：10.1021/ml400080t.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The human neuraminidase enzymes (hNEU) play important roles in human physiology and pathology. The lack of potent and selective inhibitors toward these enzymes has limited our Understanding of their function and the development of therapeutic applications. Here we report the evaluation of a,panel of compounds against the four human neuraminidase isoenzymes. Among the compounds tested, we identified the first selective, nanomolar inhibitors of the human neuraminidase 4 enzyme (NEU4). The most potent NEU4 inhibitor (5-acetamido-9-[4-hydroxymethyl[1,2,3]triazol-1-yl]-2,3,5,9-tetradeoxy-D- glycero-D-galacto-2-nonulopyranosonic acid) was found to have an inhibitory constant (K-i) of 30 +/- 19 nM and was 500-fold selective for its target over the other hNEU isoenzymes tested in vitro (NEU1, NEU2, and NEU3). This is the first report of any inhibitor of hNEU with nanomolar potency, and this'. confirms that the 2,3-didehydro-2-deoxy-N-acetylneuraminic acid (DANA) scaffold can be exploited to develop new, potent, and selective inhibitors that target this important family of human enzymes.
Keywords:
Neuraminidase
sialidase
NEU1
NEU2
NEU3
NEU4
inhibitors
sialic acid
glycosyl-hydrolase
Journal
IF:
4
Papers:
4.4K
Citations:
10.0K